EUCTR2012-002856-18-FR进行中（未招募）不适用
ALdosterone antagonist Chronic HEModialysis Interventional Survival Trial - ALCHEMIST
CHRU de Brest0 个研究点开始时间: 2013年6月14日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
ALdosterone antagonist Chronic HEModialysis Interventional Survival Trialend-stage renal failure (ESRF)cardiovascular complicationMedDRA version: 20.0Level: PTClassification code 10007649Term: Cardiovascular disorderSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10050441Term: Chronic renal insufficiencySystem Organ Class: 100000004857EUCTR2012-002856-18-BECHRU de Brest825
已完成
3 期
ALdosterone Antagonist Chronic HEModialysis Interventional Survival TrialEnd Stage Renal Failure on DialysisNCT01848639University Hospital, Brest823
进行中（未招募）
不适用
Aldosterone receptor blockade in patients with chronic kidney disease.Influence on arterial stiffness and kidney function. - ALBLOCK-2Chronic kidney disease, stages 3 and 4.MedDRA version: 9.1Level: LLTClassification code 10064848Term: Chronic kidney diseaseEUCTR2009-012445-35-DKHerlev Hospital80
进行中（未招募）
不适用
ALDOSTERONE RECEPTOR BLOCKADE IN DIASTOLIC HEART FAILUREA double-blind, randomised, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure - Aldo-DHFDiastolic Heart FailureEUCTR2006-002605-31-DEGeorg-August-Universität Göttingen
进行中（未招募）
不适用
ALDOSTERONE RECEPTOR BLOCKADE IN DIASTOLIC HEART FAILUREA double-blind, randomised, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure - Aldo-DHFDiastolic Heart FailureMedDRA version: 8.1Level: LLTClassification code 10008908Term: Chronic heart failureEUCTR2006-002605-31-ATGeorg-August-Universität Göttingen420